Ftse Mib
33.778,74
-1,51%
DAX
17.932,17
-1,10%
S&P 500
5.062,70
-1,05%
NASDAQ Composite
15.781,95
-1,26%
Bitcoin
60.068,53
-5,90%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avenue Therapeutics Inc (ATXI) Avenue Therapeutics Inc (ATXI) Notizie

Avenue Therapeutics Inc

ATXI
4,97
0,4553 (10,08%)
Ultimo aggiornamento: 21:28:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202414:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
24/4/202413:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
25/3/202413:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
18/3/202421:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
15/3/202413:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
11/3/202413:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
08/3/202422:31EDGAR2Form PRE 14C - Other preliminary information statements
08/3/202422:15EDGAR2Form 8-K - Current report
22/2/202414:30GLOBEAvenue Therapeutics Announces Publication in Drug..
02/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
29/1/202414:00EDGAR2Form DEF 14C - Other definitive information statements
24/1/202422:11EDGAR2Form S-3 - Registration statement under Securities Act of..
17/1/202423:05EDGAR2Form PRE 14C - Other preliminary information statements
12/1/202412:01EDGAR2Form 8-K - Current report
11/1/202414:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
08/1/202423:28EDGAR2Form 8-K - Current report
05/1/202415:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
04/1/202414:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
02/1/202414:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
13/12/202322:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/12/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
28/11/202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/11/202322:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/11/202319:19EDGAR2Form 8-K - Current report
13/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
02/11/202321:10EDGAR2Form 8-K - Current report
02/11/202320:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
02/11/202314:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
31/10/202314:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
05/10/202323:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/9/202323:23EDGAR2Form S-1/A - General form for registration of securities..
28/9/202322:25EDGAR2Form 8-K - Current report
27/9/202322:03EDGAR2Form 8-K - Current report
18/9/202323:18EDGAR2Form S-1 - General form for registration of securities under..
08/9/202322:15EDGAR2Form 8-K - Current report
05/9/202314:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
14/8/202322:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
11/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:20EDGAR2Form 8-K - Current report
10/8/202322:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
01/8/202314:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
27/7/202314:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
25/7/202314:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
21/7/202322:37EDGAR2Form 8-K - Current report
05/7/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 4,38 Min: 4,38 Max: 5,21
Chiusura: 4,5147

La tua Cronologia

NASDAQ
ATXI
Avenue Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network